Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=ritonavir&type0%5B%5D=AllFields&op0%5B%5D=OR&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=ritonavir&type0%5B%5D=AllFields&op0%5B%5D=OR&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=ritonavir&type0%5B%5D=AllFields&op0%5B%5D=OR&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (1.250)
1
Switch to MK-1439A from Ritonavir-boosted Protease Inhibitor regimen in HIV-1 infected subjects : A Phase III Multicenter, Open-Label, Randomized Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs).SUBTITLE: Amendment to Include Switches From Additional Antiretroviral Regimens. - Switch to MK-1439A from PI, EVG- or NNRTI-based regimen for HIV-1 infection
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Substitution current ARV therapy by BIKTARVY in hiv infected patients over 65 years old : Switch to Tenofovir Alafenamide (TAF), Emtricitabine (FTC), Bictegravir (BIC)(Biktarvy®) in HIV-1-infected patients over 65 years old at risk of polymedication - BILOLDER
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Switch to MK-1439A from Ritonavir-boosted Protease Inhibitor regimen in HIV-1 infected subjects : A Phase III Multicenter, Open-Label, Randomized Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs).SUBTITLE: Amendment to Include Switches From Additional Antiretroviral Regimens. - Switch to MK-1439A from PI, EVG- or NNRTI-based regimen for HIV-1 infection
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Substitution current ARV therapy by BIKTARVY in hiv infected patients over 65 years old : Switch to Tenofovir Alafenamide (TAF), Emtricitabine (FTC), Bictegravir (BIC)(Biktarvy®) in HIV-1-infected patients over 65 years old at risk of polymedication - BILOLDER
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Plasma concentration determination and pharmacokinetics study of Nirmatrelvir/Ritonavir tablets in children : Plasma concentration determination and pharmacokinetics study of Nirmatrelvir/Ritonavir tablets in children
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Plasma concentration determination and pharmacokinetics study of Nirmatrelvir/Ritonavir tablets in children : Plasma concentration determination and pharmacokinetics study of Nirmatrelvir/Ritonavir tablets in children
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A PHASE 3B, RANDOMISED, OPEN-LABEL STUDY OF THE ANTIVIRAL ACTIVITY AND SAFETY OF DOLUTEGRAVIR COMPARED TO LOPINAVIR/RITONAVIR BOTH ADMINISTERED WITH DUAL NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR THERAPY IN HIV-1 INFECTED ADULT SUBJECTS WITH TREATMENT FAILURE ON FIRST LINE THERAPY : A PHASE 3B, RANDOMISED, OPEN-LABEL STUDY OF THE ANTIVIRAL ACTIVITY AND SAFETY OF DOLUTEGRAVIR COMPARED TO LOPINAVIR/RITONAVIR BOTH ADMINISTERED WITH DUAL NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR THERAPY IN HIV-1 INFECTED ADULT SUBJECTS WITH TREATMENT FAILURE ON FIRST LINE THERAPY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A PHASE 3, RANDOMIZED, OPEN LABEL, CONTROLLED STUDY OF LOPINAVIR/RITONAVIR AND LAMIVUDINE VERSUS STANDARD THERAPY IN NAÏVE HIV-1 INFECTED SUBJECTS. : A PHASE 3, RANDOMIZED, OPEN LABEL, CONTROLLED STUDY OF LOPINAVIR/RITONAVIR AND LAMIVUDINE VERSUS STANDARD THERAPY IN NAÏVE HIV-1 INFECTED SUBJECTS.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A5290 RIFAMPIN-BASED TB TREATMENT VS. RIFABUTIN-BASED TB TREATMENT IN HIV : AA5290 Randomized, Phase 2b Study of a Double-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen with Rifampin-Based Tuberculosis Treatment versus a Standard-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen with Rifabutin-Based Tuberculosis Treatment with or without Raltegravir in HIV-1-Infected Persons Requiring Treatment for Active TB and HIV
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A PROSPECTIVE SINGLE ARM, OPEN-LABEL, INTERNATIONAL, MULTICENTER STUDY TO EVALUATE THE SAFETY OF ATAZANAVIR (ATV) CAPSULE BOOSTED WITH RITONAVIR (RTV) WITH AN OPTIMIZED NRTI BACKGROUND THERAPY, IN HIV INFECTED, ANTIRETROVIRAL NAÏVE AND EXPERIENCED PEDIATRIC SUBJECTS GREATER THAN OR EQUAL TO 6 YEARS TO LESS THAN 18 YEARS. : A PROSPECTIVE SINGLE ARM, OPEN-LABEL, INTERNATIONAL, MULTICENTER STUDY TO EVALUATE THE SAFETY OF ATAZANAVIR (ATV) CAPSULE BOOSTED WITH RITONAVIR (RTV) WITH AN OPTIMIZED NRTI BACKGROUND THERAPY, IN HIV INFECTED, ANTIRETROVIRAL NAÏVE AND EXPERIENCED PEDIATRIC SUBJECTS GREATER THAN OR EQUAL TO 6 YEARS TO LESS THAN 18 YEARS.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[125]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
1.250
Aufsätze
1.250
E-Artikel
1.250
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
1.244
610
1.226
Study Type: Interventional
898
Recruitment Status: Not yet recruiting
250
Phase: Phase 3
126
Recruitment Status: Authorised-recruitment may ...
120
Phase: Phase 2
118
Phase: Phase 4
82
Recruitment Status: Recruiting
78
Recruitment Status: Completed
48
Medical Condition: Chronic Hepatitis C Infectio...
20
Medical Condition: HIV-1 MedDRA version: 9.1Lev...
18
Medical Condition: Novel Coronavirus Pneumonia ...
18
Medical Condition: SARS-CoV-2 Infection MedDRA ...
18
Medical Condition: Treatment of HIV-1 infection
16
Medical Condition: Chronic Hepatitis C Infectio...
16
Medical Condition: Coronavirus Disease 2019 (CO...
16
Medical Condition: HIV
16
Medical Condition: HIV-1 infection
16
Medical Condition: The proposed indication for ...
16
Phase: Phase 1
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
438
2020-
812
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.168
Englisch
42
Spanisch
30
Unbestimmt
8
Französisch
2
Deutsch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...